DEFINITIVE PROXY STATEMENT

Company

Armata Pharmaceuticals, Inc.

Filed

March 27, 2002

Period of Report

May 9, 2002

Accession Number

0001032210-02-000482

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →